Search clinical trials for: Gemtuzumab Ozogamicin
Total 178 results
-
St. Jude Children's Research HospitalAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
Technische Universität DresdenAbbVie; University Hospital HeidelbergNot yet recruitingAcute Myeloid LeukemiaGermany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...StemlineTherapeutics, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenNot yet recruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)Germany
-
Shaare Zedek Medical CenterRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid LeukemiaUnited States
-
Centre Antoine LacassagneAcute Leukemia French AssociationNot yet recruiting
-
LLS PedAL Initiative, LLCAbbVie; Roche-Genentech; Princess Maxima Center for Pediatric Oncology (European... and other collaboratorsRecruitingAcute Myeloid LeukemiaUnited States, Canada, Denmark, Spain, Belgium, Australia, France, New Zealand, Netherlands, Czechia, Norway, Switzerland, Austria, Portugal, Italy, Sweden, Israel
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Vor BiopharmaRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Canada
-
Technische Universität DresdenPfizer; Novartis PharmaceuticalsRecruiting
-
Roswell Park Cancer InstitutePfizerRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid LeukemiaItaly
-
University of Maryland, BaltimoreHematologics, IncRecruitingAcute Myeloid Leukemia Recurrent | Acute Myeloid Leukemia, Adult | Acute Myeloid Leukemia, Relapsed, AdultUnited States
-
Uma BorateRecruiting
-
University of WashingtonPfizerRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Myeloproliferative Neoplasm | Myeloid Sarcoma | Blasts 10 Percent or More of Bone Marrow Nucleated CellsUnited States
-
University of BirminghamAssistance Publique - Hôpitaux de Paris; Pfizer; Cancer Research UK; National Cancer...RecruitingAcute Myeloid LeukaemiaFrance, Switzerland, United Kingdom, New Zealand, Australia, Ireland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Promyelocytic Leukemia With PML-RARAUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingUntreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | High Risk Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Acute Myeloid... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia
-
Robert Redner, MDPfizerActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22)... and other conditionsUnited States
-
Baylor College of MedicineWilliam Marsh Rice UniversityActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Brown UniversityPfizer; The Miriam Hospital; Rhode Island HospitalActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Versailles HospitalCompletedAcute Myeloid LeukemiaFrance
-
John QuigleyPfizer; AbbVieActive, not recruiting
-
Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles; Pfizer; Jazz PharmaceuticalsTerminatedAcute Myelogenous LeukemiaUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterPfizerCompletedAcute Myeloid LeukemiaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Puerto Rico, South Africa
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Israel
-
University Hospital HeidelbergNational Center for Tumor Diseases, HeidelbergCompletedAcute Myeloid LeukemiaGermany
-
Weill Medical College of Cornell UniversityPfizer; Jazz PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
University of UlmCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
University Hospital HeidelbergTerminated
-
Medical College of WisconsinCompletedRelapsed Adult AMLUnited States
-
Emory UniversityTerminated
-
PfizerCompletedPharmacokinetics | Safety | ECGCanada, Spain, United States, Hungary, Poland, United Kingdom
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States
-
Columbia UniversityCompletedJuvenile Myelomonocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand, Puerto Rico
-
PfizerNo longer availableCD33 Positive Acute Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompleted
-
University of California, San DiegoPfizer; Celgene CorporationCompletedAcute Myeloid LeukemiaUnited States